31/10/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
03/08/23 GSK Nigeria calls an end to its business, to return cash RE
03/08/23 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
03/08/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
28/04/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
28/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
28/01/23 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/10/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
29/07/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
28/04/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
31/01/22 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
25/10/21 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
29/07/21 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 01/08/2011
General Counsel - 01/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
+1.81%+11.60%+58.61%+164.79% 1,097B
+1.51%+11.77%+69.61%+57.53% 622B
+0.38%+10.56%+39.49%+90.88% 449B
-0.80%+6.34%+29.51%+24.01% 334B
+1.29%+6.86%+43.50%+28.79% 294B
+1.09%+3.42%+32.72%+41.82% 286B
+1.38%+3.98%-27.21%-41.79% 213B
+0.62%+4.59%+30.10%+63.03% 195B
-1.21%+1.17%+14.15%+66.20% 157B
Average +0.06%+6.79%+32.28%+55.03% 405.19B
Weighted average by Cap. +0.04%+8.72%+43.77%+82.14%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock